V. Valkhoff

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
V. E. Valkhoff, Vera Valkhoff, V. Valkhoff, Vera E Valkhoff, Vera E. Valkhoff
Publication record
50 papers · 1,940 citations · H-index 19

PAPERS

Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands
202014 citationsauthor #7
Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project
201852 citationsauthor #11
Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project
201856 citationsauthor #16
Prevalence of hospital admissions related to medication in the Netherlands between 2008 and 2013
20180 citationsauthor #6
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study
2016222 citationsauthor #14
Individualized NSAID prescribing based on gastrointestinal and cardiovascular risks: A decision model in the SOS project
20150 citationsauthor #2
Adverse drug reactions in a primary care population prescribed non-steroidal anti-inflammatory drugs
201510 citationsauthor #3
Quick assessment of drug‐related admissions over time (QUADRAT study)
201514 citationsauthor #2
Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
201521 citationsauthor #3
Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk.
201461 citationsauthor #1
Authors' response.
20140 citationsauthor #2
Ischaemic cardiovascular risk and prescription of non-steroidal anti-inflammatory drugs for musculoskeletal complaints
201410 citationsauthor #2
Risk of upper gastrointestinal bleeding from different drug combinations.
2014174 citationsauthor #2
Development and application of indicators for the reduction of potentially preventable hospital admissions related to medications
20142 citationsauthor #2
High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study.
201490 citationsauthor #2
Cyclo‐oxygenase‐2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
201315 citationsauthor #2
Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?
201343 citationsauthor #1
Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus.
2013193 citationsauthor #5
Sa1960 Risk of Upper Gastrointestinal Complications and the Use of Individual NSAIDs: A Nested Case-Control Study From the Sos Project
20130 citationsauthor #1
PS11 - 4. Use of Glucose Lowering Drugs and the Risk of Adenocarcinoma Among Patients With Type 2 Diabetes: A Case-Control Study in The Netherlands
20130 citationsauthor #3
Reply: To PMID 23470618.
20131 citationsauthor #2
Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies.
201329 citationsauthor #1
OP0202-PC Use of Over-the-Counter Non-Steroidal Anti-Inflammatory Drugs in the General Population and in Patients with a High Risk of Adverse Drug Events
20133 citationsauthor #2
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries
2013124 citationsauthor #2
New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis.
2013398 citationsauthor #2
Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries
201320 citationsauthor #9
OP0187-PC Potentially harmful prescription of NSAIDS in a primary care population with musculoskeletal complaints
20131 citationsauthor #3
1037 The Choice of NSAID Treatment With Respect To Upper Gastrointestinal Complications and Cardiovascular Complications: A Treatment Decision Model Using Multiple Healthcare Databases
20133 citationsauthor #1
812 Synergistic Effects of Concomitant Use of Non-Selective NSAIDs, Coxibs and Low-Dose Aspirin on Risk of Upper Gastrointestinal Bleeding
20131 citationsauthor #2
Su1801 Incidence of Upper Gastrointestinal Complications Estimated From Different Data Sources in the Safety of NSAIDs (SOS) Project
20120 citationsauthor #2
Use and Safety of Non-Steroidal Inflammatory Drugs and Aspirin
20122 citationsauthor #1
Tuesday, 28 August 2012
20121 citationsauthor #2510
Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
201284 citationsauthor #1
Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal ‐ a 617 400‐patient study
201214 citationsauthor #1
Su1803 Validation of the Diagnosis for Upper Gastrointestinal Bleeding in a Dutch Medical Record Database
20122 citationsauthor #1
Su1769 NSAID use Among Children in Europe in the SOS Project
20120 citationsauthor #1
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study.
201218 citationsauthor #1
Su1788 New Oral Anticoagulants and the Risk of Gastrointestinal Bleeding - a Systematic Review
20123 citationsauthor #2
Time-Trends in Use of Gastroprotective Strategies With NSAID Treatment in the United Kingdom, Italy, and the Netherlands; A Comparative Study
20111 citationsauthor #1
Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases
201172 citationsauthor #2
Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
201139 citationsauthor #1
[Clopidogrel and proton pump inhibitors: insufficient evidence of interaction].
20111 citationsauthor #2
Adherence to Gastroprotective Agents and the Risk of Upper Gastrointestinal Complications in Coxib Users
20111 citationsauthor #1
NHERF1 and NHERF2 are necessary for multiple but usually separate aspects of basal and acute regulation of NHE3 activity.
201150 citationsauthor #2
Suboptimal Gastroprotective Coverage of NSAID Use and the Risk of Upper Gastrointestinal Complications
20111 citationsauthor #2
Time-trends in gastroprotection with NSAIDs
201037 citationsauthor #1
T1853 NHERF1 and NHERF2 Separately Contribute to Basal and Acutely Regulated NHE3 Activity. An Exception is cAMP Inhibiton Which Can Be Mediated Either by NHERF1 or NHERF2
20100 citationsauthor #2
Time‐trends in gastroprotection with nonsteroidal anti‐inflammatory drugs (NSAIDs)
201050 citationsauthor #1
740 Concomitant use of a Proton Pump Inhibitor Does Not Increase the Risk of Recurrent Myocardial Infarction Among Clopidogrel Users
20103 citationsauthor #1
T1965 Changes in Overuse and Underuse of Prophylactic Strategies with NSAID Treatment Over the Past Decade; Further Improvement Is Needed
20090 citationsauthor #1

TIMELINE

2009 0 citations

2010 90 citations

2011 165 citations

2012 124 citations

2013 831 citations

2014 337 citations

2015 45 citations

2016 222 citations

2018 108 citations

2020 14 citations

COAUTHOR MAP

CONCEPT FOOTPRINT